Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
暂无分享，去创建一个
M. Abbasian | K. Peggs | F. Farzaneh | V. Spanswick | J. Hartley | D. Linch | H. Lowe | M. Lowdell | L. Clifton-Hadley | Leticia Bosshard-Carter | G. Wheeler | M. Pule | D. Irvine | B. Popova | C. Roddie | Harriet Roddy | M. Marzolini | M. O'Reilly | A. Bloor | Ketki Vispute | Juliana Dias | Amaia Cadinanos-Garai | Marina Mitsikakou | Vedika Mehra | Jo Olejnik | Leigh Wood | Sabine Domning | S. Domning | J. Dias | M. Mitsikakou | L. Wood | Amaia Cadiñanos-Garai